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The incidence of extrapulmonary (EP) tuberculosis (TB) 
is increased in patients with advanced HIV infection.1,2 
Mammary TB is a rare manifestation of EPTB, and this 
report describes a case of TB mastitis and TB-associated 
immune reconstitution syndrome (IRIS) with advanced 
HIV infection.
CASE REPORT
A 34-year-old woman presented with a 2-month history 
of loss of weight, non-productive cough and painful 
swelling of the right breast. There was no past history 
of TB, and the patient did not know her HIV status. 
Clinical examination revealed a unilateral 10x8 cm mass 
in the upper outer quadrant of the breast, with no lymph 
node involvement. A fine-needle aspirate (FNA) was 
performed and the mass was then incised, drained and 
dressed. Acid-fast bacilli (AFB) were isolated from the 
FNA using an auramine stain, and the mycobacterial 
growth indicator tube culture was positive at 3 weeks. 
The Mycobacterium tuberculosis (MTB) strain isolated 
was sensitive to all anti-TB drugs. In addition, concurrent 
pulmonary tuberculosis (PTB) was diagnosed through a 
positive sputum AFB smear and compatible changes 
on the chest radiograph (CXR). The CXR also showed 
no communication between the lung and chest wall. 
The intensive phase (IP) of TB treatment, consisting of 
rifampicin, isoniazid, pyrazinamide and ethambutol, was 
commenced. An uneventful clinical course followed on 
TB treatment, and the breast mass resolved completely. 
The patient accepted counselling and testing for HIV on 
diagnosis of PTB and was found to be HIV infected.
Sputum smear reversion occurred 2 months after TB 
diagnosis. The patient was commenced on antiretroviral 
therapy (ART) after 3 months of TB treatment. A once-
daily regimen of didanosine, efavirenz and lamivudine 
was chosen because of its substantial potency and 
tolerability with TB treatment. The patient presented 
2 weeks after initiation of ART with a 4-day history of 
a painful sternal mass. Clinical findings included new-
onset generalised lymphadenopathy, a 3 cm tender 
erythematous sternal mass with overlying desquamation, 
a 5 cm firm non-tender right breast mass recurring in 
the previous site, and two 10 cm soft, non-tender mobile 
masses, one over the left scapula and the other centrally 
over the spinal column. A full blood count demonstrated 
bicytopenia, neutropenia and normochromic anaemia 
with abnormally low folate levels. The patient’s CD4 
count was 163 cells/µl and her viral load 932 553 copies/
ml (log 5.97).
Staphylococcus aureus was isolated from a pus swab 
of the sternal lesion and treated with a course of 
flucloxacillin. A Ziehl-Neelsen stain of an FNA of the 
breast mass isolated AFB but was culture negative. 
Cytology demonstrated thick inflammatory/necrotic 
debris with numerous epithelial granulomas, and no 
ductal cells. 
The patient completed 7 months of TB treatment and 
uninterrupted ART. Eighteen months after ART initiation, 
her CD4 count was 480 cells/µl with an undetectable 
viral load. The sternal and breast masses had resolved 
completely. However, the patient refused excision biopsy 
for histologically confirmed lipomas on the posterior 
chest wall. 
DISCUSSION
In the pre-AIDS era, incidence rates of TB mastitis were 
0.1% and 3% of all breast lesions in developed and 
developing countries, respectively.3 However, reports 
of TB of the breast are becoming more common with 
the advancing HIV epidemic, especially over the past 
decade (Table I). 
In immunocompromised patients in particular, 
haematogenous spread of MTB from a primary focus 
can result in mammary TB. The primary site of TB in this 
report was the lung parenchyma. TB of the breast most 
commonly presents as a lump in the central or upper 
outer quadrant of the breast,18 as in this case. Diagnosis 
is based on multiple factors including clinical history, 
examination, histological features, and in some cases 
response to empiric TB treatment. FNA of the breast lesion 
remains the single most important diagnostic method.14 
Histopathological examination reveals suppuration and 
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a degree of necrotising inflammation that is uncommon 
in profoundly immunocompromised patients.19  
The development of the breast mass after initiation of 
ART may be related to the unmasking of TB-associated 
IRIS. It is unusual for MTB-associated IRIS to present 
as a breast mass; commonly fever, lymphadenopathy 
or worsening pulmonary symptoms characterise MTB 
IRIS. 
This case highlights the need for a high index of suspicion 
of EPTB presenting in unusual sites particularly against 
a background of high TB and HIV prevalence. It also 
demonstrates the clinical diagnostic and management 
dilemmas faced by clinicians in this setting.
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Pattern of drug- 
resistant TB, site
Kalaç et al.4     5     4 1 RI resistance, lung
Tewari and Shukla5   30   30 - -
Khanna et al.6   52   52 - -
Green and Ormerod7   10     5 5 IE resistance, breast
Morino et al.8     2     1 1 -
Sakr et al.9   10   10 - -
Ahmed and Sultan10   10     2 8 -
Sriram et al.11*     1     1 - -
Fadaei-Araghi et al.12     8     1 - -
Kumar and Sharma13     1     1 - RIS resistance, breast
Kakkar et al.14 164 164 - -
O’Reilly et al.15     1     1 - -
Al-Marri et al.16   13   13 - -
Harris et al.17   38   33 5 -
*This was the only report that documented HIV status; the patient was HIV uninfected.
R =  rifampicin; I = isoniazid; E = ethambutol; S = streptomycin.
TABLE I. SUMMARy OF LITERATURE REVIEW OF TB MASTITIS CASES
